GSA Capital Partners’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,973	Closed	-$273K	–	2053
2025 Q1	$273K	Buy	+10,973	New	+$263K	0.02%	1217
2024 Q2	–	Sell	-22,722	Closed	-$664K	–	1938
2024 Q1	$664K	Sell	22,722 -2,030	-8%	-$62.4K	0.05%	711
2023 Q4	$835K	Buy	+24,752	New	+$724K	0.07%	487
2023 Q2	–	Sell	-22,384	Closed	-$913K	–	1840
2023 Q1	$913K	Sell	22,384 -11,835	-35%	-$471K	0.09%	363
2022 Q4	$1.32M	Buy	+34,219	New	+$1.66M	0.16%	93
2020 Q2	–	Sell	-21,875	Closed	-$733K	–	988
2020 Q1	$733K	Buy	+21,875	New	+$909K	0.18%	44
2019 Q4	–	Sell	-16,592	Closed	-$632K	–	1655
2019 Q3	$632K	Sell	16,592 -19,451	-54%	-$776K	0.09%	406
2019 Q2	$1.57M	Buy	+36,043	New	+$1.53M	0.18%	83
2019 Q1	–	Sell	-7,400	Closed	-$318K	–	1627
2018 Q4	$318K	Buy	+7,400	New	+$345K	0.04%	809
2016 Q3	–	Sell	-29,900	Closed	-$1.01M	–	1912
2016 Q2	$1.01M	Buy	29,900 +19,800	+196%	+$973K	0.06%	620
2016 Q1	$535K	Buy	+10,100	New	+$591K	0.03%	973
2015 Q3	–	Sell	-18,550	Closed	-$1.31M	–	1966
2015 Q2	$1.31M	Sell	18,550 -8,700	-32%	-$685K	0.05%	679
2015 Q1	$2.42M	Buy	27,250 +17,700	+185%	+$1.8M	0.1%	242
2014 Q4	$847K	Sell	9,550 -3,821	-29%	-$361K	0.06%	575
2014 Q3	$1.3M	Buy	+13,371	New	+$1.3M	0.07%	356
2014 Q2	–	Sell	-32,197	Closed	-$2.25M	–	1925
2014 Q1	$2.25M	Buy	32,197 +16,392	+104%	+$1.11M	0.16%	121
2013 Q4	$909K	Buy	15,805 +9,251	+141%	+$486K	0.07%	428
2013 Q3	$315K	Sell	6,554 -11,983	-65%	-$437K	0.02%	1114
2013 Q2	$538K	Buy	+18,537	New	+$536K	0.06%	503